Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA

Biochemical and Biophysical Research Communications

Volumn 415, Issue 2, 2011, Pages 325-329

  Jiang, Jiahua ^a   Jedinak, Andrej ^a   Sliva, Daniel ^a,b,c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CDC20; Ganoderma lucidum; Ganodermanontriol; Invasive breast cancer; UPA

Indexed keywords

ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN 20; GANODERMA LUCIDUM EXTRACT; GANODERMANONTRIOL; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR;

ANCHORAGE DEPENDENT GROWTH; ANCHORAGE INDEPENDENT GROWTH; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CELL ANCHORAGE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; LANOSTEROL; NEOPLASM INVASIVENESS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

BASIDIOMYCOTA; GANODERMA; GANODERMA LUCIDUM;

EID: 84855871486     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.055     Document Type: Article

References (33)

1. Jemal A., Siegel R., Xu J., et al. Cancer Statistics, 2010, CA Cancer. J. Clin. 2010, 60:277-300.
2. Price J.T., Bonovich M.T., Kohn E.C. The biochemistry of cancer dissemination. Crit. Rev. Biochem. Mol. Biol. 1997, 32:175-253.
3. Kim H.J., Chang W.K., Kim M.K., et al. Dietary factors and gastric cancer in Korea: a case-control study. Int. J. Cancer 2002, 97:531-535.
4. Hara M., Hanaoka T., Kobayashi M., et al. Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr. Cancer 2003, 46:138-147.
5. Zhang M., Huang J., Xie X., et al. Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int. J. Cancer 2009, 124:1404-1408.
6. Shin A., Kim J., Lim S.Y., et al. Dietary mushroom intake and the risk of breast cancer based on hormone receptor status. Nutr. Cancer 2010, 62:476-483.
7. Sliva D. Cellular and physiological effects of Ganoderma lucidum (Reishi). MiniRev. Med. Chem. 2004, 4:873-879.
8. American Herbal Pharmacopoeia, Reishi Mushroom http://www.herbal-ahp.org.
9. Lin Z.B. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J. Pharmacol. Sci. 2005, 99:144-153.
10. Li C.H., Chen P.Y., Chang U.M., et al. Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci. 2005, 77:252-265.
11. Tang W., Liu J.W., Zhao W.M., et al. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci. 2006, 80:205-211.
12. Yue Q.X., Cao Z.W., Guan S.H., et al. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol. Cell. Proteomics 2008, 7:949-961.
13. Jiang J., Grieb B., Thyagarajan A., et al. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int. J. Mol. Med. 2008, 21:577-584.
14. Liu R.M., Zhong J.J. Ganoderic acid Mf and S induce mitochondria mediated apoptosis in human cervical carcinoma HeLa cells. Phytomedicine 2011, 18:349-355.
15. Weng C.J., Chau C.F., Hsieh Y.S., et al. Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 2008, 29:147-156.
16. Hsu C.L., Yu Y.S., Yen G.C. Lucidenic acid B induces apoptosis in human leukemia cells via a mitochondria-mediated pathway. J. Agric. Food Chem. 2008, 56:3973-3980.
17. Thyagarajan A., Jedinak A., Nguyen H., et al. Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr. Cancer 2010, 62:630-640.
18. Kimura Y., Taniguchi M., Baba K. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res. 2002, 22:3309-3318.
19. Weng C.J., Chau C.F., Yen G.C., et al. Inhibitory effects of Ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. J. Agric. Food Chem. 2009, 57:5049-5057.
20. Chen N.H., Liu J.W., Zhong J.J. Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. Pharmacol. Rep. 2010, 62:150-163.
21. Kidokoro T., Tanikawa C., Furukawa Y., et al. CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene 2008, 27:1562-1571.
22. Wasch R., Engelbert D. Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cells. Oncogene 2005, 24:1-10.
23. Jiang J., Slivova V., Harvey K., et al. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr. Cancer 2004, 49:209-216.
24. Slivova V., Valachovicova T., Jiang J., et al. Ganoderma lucidum inhibits invasiveness of breast cancer cells. J. Cancer Integr. Med. 2004, 2:25-30.
25. Lloyd F.P., Slivova V., Valachovicova T., et al. Aspirin inhibits highly invasive prostate cancer cells. Int. J. Oncol. 2003, 23:1277-1283.
26. Sliva D., Labarrere C., Slivova V., et al. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem. Biophys. Res. Commun. 2002, 298:603-612.
27. Jiang J., Chang H.-L., Sugimoto Y., et al. Effects of age on growth and ERbeta mRNA expression of canine prostatic cells. Anticancer Res. 2005, 25:4081-4090.
28. Jedinak A., Thyagarajan-Sahu A., Jiang J., et al. Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through β-catenin signaling. Int. J. Oncol. 2011, 38:761-767.
29. Wang L.H. Molecular signaling regulating anchorage-independent growth of cancer cells. Mt. Sinai J. Med. 2004, 71:361-367.
30. Yuan B., Xu Y., Woo J.H., et al. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin. Cancer Res. 2006, 12:405-410.
31. Chen N.H., Liu J.W., Zhong J.J. Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. J. Pharmacol. Sci. 2008, 108:212-216.
32. Chen N.H., Zhong J.J. P53 is important for the anti-invasion of ganoderic acid T in human carcinoma cells. Phytomedicine 2011, 18:719-725.
33. Weng C.J., Chau C.F., Chen K.D., et al. The anti-invasive effect of lucidenic acids isolated from a new Ganoderma lucidum strain. Mol. Nutr. Food Res. 2007, 51:1472-1477.